Process for purifying proteins and compounds useful in such process

• US 4,569,794 A
• Filed: 12/05/1984
• Issued: 02/11/1986
• Est. Priority Date: 12/05/1984
• Status: Expired due to Term

• Current Assignee: Eli Lilly and Company
• Original Assignee: Eli Lilly and Company
• Inventors: Pidgeon, Charles, Smith, Michele C.
• Primary Examiner(s): Schain, Howard E.
• Application Number:
  US06/678,602
• Time in Patent Office: 433 Days
• Field of Search: 260/112 R, 260/112.5 S, 260/112.5 R, 260/113, 260/114, 260/115, 260/112.7, 260/121, 260/112.5 LH, 260/112.5 E
• US Class Current: 530/344
• CPC Class Codes: B01J 20/223 containing metals, e.g. organo-metallic compounds, coordination complexes
• CPC Class Codes: B01J 20/286 Phases chemically bonded to a substrate, e.g. to silica or to polymers
• CPC Class Codes: B01J 20/3212 consisting of a polymer obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
• CPC Class Codes: B01J 20/3265 with an organic functional group containing a metal, e.g. a metal affinity ligand
• CPC Class Codes: B01J 2220/49 Materials comprising an indicator, e.g. colour indicator, pH-indicator
• CPC Class Codes: B01J 2220/54 Sorbents specially adapted for analytical or investigative chromatography
• CPC Class Codes: B01J 2220/58 Use in a single column
• CPC Class Codes: C07K 1/22 Affinity chromatography or related techniques based upon selective absorption processes
• CPC Class Codes: C07K 2319/00 Fusion polypeptide
• CPC Class Codes: C07K 2319/20 containing a tag with affinity for a non-protein ligand
• CPC Class Codes: C07K 2319/50 containing protease site
• CPC Class Codes: C12N 15/62 DNA sequences coding for fusion proteins

Abstract

This invention describes a process for separating a biologically active polypeptide or protein in the form of its precursor from a mixture containing said precursor and impurities, which comprises contacting said precursor with a resin containing immobilized metal ions, said precursor comprising the biologically active polypeptide or protein covalently linked directly or indirectly to an immobilized metal ion chelating peptide, binding said precursor to said resin, and selectively eluting said precursor from said resin. Such precursor compounds are also described.

Claims

1. A compound comprising a biologically active polypeptide or protein covalently linked directly or indirectly to an immobilized metal ion chelating peptide.

2. Compound of claim 1, in which the immobilized metal ion chelating peptide has from 2 to about 5 amino acids.

3. Compound of claim 2, in which the immobilized metal ion chelating peptide contains at least one amino acid selected from the group consisting of histidine and cysteine.

4. Compound of claim 3, in which at least one amino acid of the immobilized metal ion chelating peptide is histidine.

5. Compound of claim 4 in which the immobilized metal ion chelating peptide has the formula His-X in which X is selected from the group consisting of -Gly-His, -Tyr, -Gly, -Trp, -Val, -Leu, -Ser, -Lys, -Phe, -Met, -Ala, -Glu, -Ile, -Thr, -Asp, -Asn, -Gln, -Arg, -Cys, and -Pro.

6. Compound of claim 5, in which X is selected from the group consisting of -Trp, -Tyr, -Gly-His, and -Phe.

7. Compound of claim 6, in which X is selected from the group consisting of -Trp, -Tyr, and -Gly-His.

8. Compound of claim 4, in which the immobilized metal ion chelating peptide has the formula Y-His in which Y is selected from the group consisting of -Gly, -Ala, and -Tyr.

9. Compound of claim 1, in which the immobilized metal ion chelating peptide is convalently linked directly or indirectly to the biologically active polypeptide or protein at the amino terminus of the latter.

10. Compound of claim 9, in which the immobilized metal ion chelating peptide is covalently linked indirectly via a selective cleavage site to the biologically active polypeptide or protein at the amino terminus of the latter.

11. Compound of claim 1, in which the immobilized metal ion chelating peptide chelates nickel (II) ion.

12. Compound of claim 1, in which the biologically active polypeptide or protein has the amino acid sequence of an insulin A-chain, an insulin B-chain, a proinsulin, or a growth hormone.

14. Process of claim 12, in which the immobilized metal ion chelating peptide has from 2 to about 5 amino acids.

15. Process of claim 14, in which the immobilized metal ion chelating peptide contains at least one amino acid selected from the group consisting of histidine and cysteine.

16. Process of claim 15, in which at least one amino acid of the immobilized metal ion chelating peptide is histidine.

17. Process of claim 16, in which the immobilized metal ion chelating peptide has the formula His-X in which X is selected from the group consisting of -Gly-His, -Tyr, -Gly, -Trp, -Val, -Leu, -Ser, -Lys, -Phe, -Met, -Ala, -Glu, -Ile, -Thr, -Asp, -Asn, -Gln, -Arg, -Cys, and -Pro.

18. Process of claim 17, in which X is selected from the group consisting of -Trp, -Tyr, -Gly-His, and -Phe.

19. Process of claim 18, in which X is selected from the group consisting of -Trp, -Tyr, and -Gly-His.

20. Process of claim 16, in which the immobilized metal ion chelating peptide has the formula Y-His in which Y is selected from the group consisting of -Gly, -Ala, and -Tyr.

13. Process for separating a biologically active polypeptide or protein in the form of its precursor from a mixture containing said precursor and impurities, which comprises contacting said precursor with a resin containing immobilized metal ions, said precursor comprising the biologically active polypeptide or protein covalently linked directly or indirectly to an immobilized metal ion chelating peptide, binding said precursor to said resin, and selectively eluting said precursor from said resin.

21. Process of claim 13, in which the immobilized metal ion chelating peptide is covalently linked directly or indirectly to the biologically active polypeptide or protein at the amino terminus of the latter.

22. Process of claim 21, in which the immobilized metal ion chelating peptide is covalently linked indirectly via a selective cleavage site to the biologically active polypeptide or protein at the amino terminus of the latter.

23. Process of claim 13, in which the biologically active polypeptide or protein has the amino acid sequence of an insulin A-chain, an insulin B-chain, a proinsulin, or a growth hormone.

24. Process of claim 13, in which the resin containing immobilized metal ions is selected from the group consisting of chelating Sepharose 6B, Immobilized Iminodiacetic Acid I, Immobilized Iminodiacetic Acid II, and Chelex 100.

25. Process of claim 13, in which the immobilized metal ion is the divalent ion of metals selected from the group consisting of cobalt, nickel, and copper.

26. Process of claim 25, in which the immobilized metal ion is the divalent ion of metals selected from the group consisting of nickel and copper.

27. Process of claim 26, in which the immobilized metal ion is nickel (II).